| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 18 | 
| NetGPI | no | yes: 0, no: 18 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0016020 | membrane | 2 | 2 | 
| GO:0110165 | cellular anatomical entity | 1 | 4 | 
| GO:0005739 | mitochondrion | 5 | 2 | 
| GO:0043226 | organelle | 2 | 2 | 
| GO:0043227 | membrane-bounded organelle | 3 | 2 | 
| GO:0043229 | intracellular organelle | 3 | 2 | 
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 | 
Related structures:
AlphaFold database: E9B226
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0006082 | organic acid metabolic process | 3 | 2 | 
| GO:0006629 | lipid metabolic process | 3 | 2 | 
| GO:0006631 | fatty acid metabolic process | 4 | 2 | 
| GO:0006635 | fatty acid beta-oxidation | 6 | 2 | 
| GO:0008152 | metabolic process | 1 | 2 | 
| GO:0009056 | catabolic process | 2 | 2 | 
| GO:0009062 | fatty acid catabolic process | 5 | 2 | 
| GO:0009987 | cellular process | 1 | 2 | 
| GO:0016042 | lipid catabolic process | 4 | 2 | 
| GO:0016054 | organic acid catabolic process | 4 | 2 | 
| GO:0019395 | fatty acid oxidation | 5 | 2 | 
| GO:0019752 | carboxylic acid metabolic process | 5 | 2 | 
| GO:0030258 | lipid modification | 4 | 2 | 
| GO:0032787 | monocarboxylic acid metabolic process | 6 | 2 | 
| GO:0034440 | lipid oxidation | 5 | 2 | 
| GO:0043436 | oxoacid metabolic process | 4 | 2 | 
| GO:0044237 | cellular metabolic process | 2 | 2 | 
| GO:0044238 | primary metabolic process | 2 | 2 | 
| GO:0044242 | cellular lipid catabolic process | 4 | 2 | 
| GO:0044248 | cellular catabolic process | 3 | 2 | 
| GO:0044255 | cellular lipid metabolic process | 3 | 2 | 
| GO:0044281 | small molecule metabolic process | 2 | 2 | 
| GO:0044282 | small molecule catabolic process | 3 | 2 | 
| GO:0046395 | carboxylic acid catabolic process | 5 | 2 | 
| GO:0071704 | organic substance metabolic process | 2 | 2 | 
| GO:0072329 | monocarboxylic acid catabolic process | 6 | 2 | 
| GO:1901575 | organic substance catabolic process | 3 | 2 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 19 | 
| GO:0004165 | delta(3)-delta(2)-enoyl-CoA isomerase activity | 5 | 12 | 
| GO:0016853 | isomerase activity | 2 | 19 | 
| GO:0016860 | intramolecular oxidoreductase activity | 3 | 12 | 
| GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds | 4 | 12 | 
| GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity | 5 | 4 | 
| GO:0016491 | oxidoreductase activity | 2 | 4 | 
| GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 4 | 
| GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 4 | 
| GO:0004300 | enoyl-CoA hydratase activity | 5 | 2 | 
| GO:0016829 | lyase activity | 2 | 2 | 
| GO:0016835 | carbon-oxygen lyase activity | 3 | 2 | 
| GO:0016836 | hydro-lyase activity | 4 | 2 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.608 | 
| CLV_NRD_NRD_1 | 296 | 298 | PF00675 | 0.289 | 
| CLV_NRD_NRD_1 | 340 | 342 | PF00675 | 0.586 | 
| CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.603 | 
| CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.289 | 
| CLV_PCSK_PC7_1 | 292 | 298 | PF00082 | 0.268 | 
| CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.328 | 
| CLV_PCSK_SKI1_1 | 83 | 87 | PF00082 | 0.391 | 
| DEG_APCC_DBOX_1 | 296 | 304 | PF00400 | 0.274 | 
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.612 | 
| DEG_SPOP_SBC_1 | 4 | 8 | PF00917 | 0.714 | 
| DOC_CYCLIN_RxL_1 | 236 | 247 | PF00134 | 0.285 | 
| DOC_CYCLIN_yClb5_NLxxxL_5 | 327 | 333 | PF00134 | 0.416 | 
| DOC_PP2B_LxvP_1 | 219 | 222 | PF13499 | 0.363 | 
| DOC_PP2B_LxvP_1 | 281 | 284 | PF13499 | 0.360 | 
| DOC_PP4_FxxP_1 | 166 | 169 | PF00568 | 0.288 | 
| DOC_PP4_FxxP_1 | 63 | 66 | PF00568 | 0.461 | 
| DOC_USP7_MATH_1 | 284 | 288 | PF00917 | 0.249 | 
| DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.577 | 
| DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.288 | 
| DOC_WW_Pin1_4 | 175 | 180 | PF00397 | 0.262 | 
| DOC_WW_Pin1_4 | 244 | 249 | PF00397 | 0.288 | 
| DOC_WW_Pin1_4 | 319 | 324 | PF00397 | 0.246 | 
| LIG_14-3-3_CanoR_1 | 11 | 17 | PF00244 | 0.550 | 
| LIG_14-3-3_CanoR_1 | 279 | 284 | PF00244 | 0.391 | 
| LIG_14-3-3_CanoR_1 | 29 | 34 | PF00244 | 0.550 | 
| LIG_BIR_III_2 | 58 | 62 | PF00653 | 0.600 | 
| LIG_BRCT_BRCA1_1 | 19 | 23 | PF00533 | 0.423 | 
| LIG_deltaCOP1_diTrp_1 | 158 | 166 | PF00928 | 0.288 | 
| LIG_FHA_1 | 117 | 123 | PF00498 | 0.313 | 
| LIG_FHA_1 | 13 | 19 | PF00498 | 0.649 | 
| LIG_FHA_1 | 315 | 321 | PF00498 | 0.277 | 
| LIG_LIR_Apic_2 | 165 | 169 | PF02991 | 0.287 | 
| LIG_LIR_Apic_2 | 62 | 66 | PF02991 | 0.491 | 
| LIG_LIR_Gen_1 | 158 | 167 | PF02991 | 0.268 | 
| LIG_LIR_Gen_1 | 278 | 284 | PF02991 | 0.288 | 
| LIG_LIR_Gen_1 | 298 | 304 | PF02991 | 0.139 | 
| LIG_LIR_Gen_1 | 313 | 323 | PF02991 | 0.283 | 
| LIG_LIR_Nem_3 | 158 | 163 | PF02991 | 0.279 | 
| LIG_LIR_Nem_3 | 278 | 283 | PF02991 | 0.288 | 
| LIG_LIR_Nem_3 | 313 | 319 | PF02991 | 0.379 | 
| LIG_LYPXL_SIV_4 | 273 | 281 | PF13949 | 0.432 | 
| LIG_PCNA_PIPBox_1 | 326 | 335 | PF02747 | 0.360 | 
| LIG_PCNA_yPIPBox_3 | 326 | 339 | PF02747 | 0.311 | 
| LIG_Pex14_2 | 152 | 156 | PF04695 | 0.288 | 
| LIG_Pex14_2 | 315 | 319 | PF04695 | 0.391 | 
| LIG_SH2_CRK | 229 | 233 | PF00017 | 0.271 | 
| LIG_SH2_STAP1 | 229 | 233 | PF00017 | 0.271 | 
| LIG_SH2_STAP1 | 311 | 315 | PF00017 | 0.276 | 
| LIG_SH2_STAT3 | 28 | 31 | PF00017 | 0.607 | 
| LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.299 | 
| LIG_SH2_STAT5 | 299 | 302 | PF00017 | 0.387 | 
| LIG_SH2_STAT5 | 332 | 335 | PF00017 | 0.336 | 
| LIG_SH3_3 | 138 | 144 | PF00018 | 0.432 | 
| LIG_SH3_3 | 217 | 223 | PF00018 | 0.381 | 
| LIG_SH3_3 | 317 | 323 | PF00018 | 0.314 | 
| LIG_SH3_3 | 33 | 39 | PF00018 | 0.615 | 
| LIG_SH3_3 | 63 | 69 | PF00018 | 0.455 | 
| LIG_SUMO_SIM_anti_2 | 99 | 105 | PF11976 | 0.169 | 
| LIG_SxIP_EBH_1 | 120 | 134 | PF03271 | 0.301 | 
| LIG_TRAF2_1 | 115 | 118 | PF00917 | 0.416 | 
| LIG_TRAF2_1 | 264 | 267 | PF00917 | 0.473 | 
| LIG_TRAF2_1 | 305 | 308 | PF00917 | 0.336 | 
| MOD_CK1_1 | 7 | 13 | PF00069 | 0.720 | 
| MOD_CK2_1 | 112 | 118 | PF00069 | 0.370 | 
| MOD_CK2_1 | 302 | 308 | PF00069 | 0.336 | 
| MOD_CMANNOS | 109 | 112 | PF00535 | 0.288 | 
| MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.302 | 
| MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.270 | 
| MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.509 | 
| MOD_GSK3_1 | 112 | 119 | PF00069 | 0.310 | 
| MOD_GSK3_1 | 123 | 130 | PF00069 | 0.265 | 
| MOD_GSK3_1 | 3 | 10 | PF00069 | 0.684 | 
| MOD_GSK3_1 | 310 | 317 | PF00069 | 0.422 | 
| MOD_N-GLC_1 | 202 | 207 | PF02516 | 0.301 | 
| MOD_N-GLC_1 | 212 | 217 | PF02516 | 0.293 | 
| MOD_N-GLC_1 | 44 | 49 | PF02516 | 0.640 | 
| MOD_NEK2_1 | 212 | 217 | PF00069 | 0.296 | 
| MOD_NEK2_1 | 23 | 28 | PF00069 | 0.458 | 
| MOD_NEK2_1 | 232 | 237 | PF00069 | 0.139 | 
| MOD_PIKK_1 | 23 | 29 | PF00454 | 0.514 | 
| MOD_PIKK_1 | 314 | 320 | PF00454 | 0.287 | 
| MOD_PK_1 | 279 | 285 | PF00069 | 0.391 | 
| MOD_PKA_1 | 67 | 73 | PF00069 | 0.592 | 
| MOD_Plk_1 | 202 | 208 | PF00069 | 0.154 | 
| MOD_Plk_1 | 44 | 50 | PF00069 | 0.463 | 
| MOD_Plk_4 | 127 | 133 | PF00069 | 0.306 | 
| MOD_ProDKin_1 | 175 | 181 | PF00069 | 0.262 | 
| MOD_ProDKin_1 | 244 | 250 | PF00069 | 0.288 | 
| MOD_ProDKin_1 | 319 | 325 | PF00069 | 0.246 | 
| MOD_SUMO_rev_2 | 115 | 122 | PF00179 | 0.389 | 
| TRG_DiLeu_BaEn_2 | 70 | 76 | PF01217 | 0.544 | 
| TRG_ENDOCYTIC_2 | 191 | 194 | PF00928 | 0.432 | 
| TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.288 | 
| TRG_ENDOCYTIC_2 | 299 | 302 | PF00928 | 0.387 | 
| TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.611 | 
| TRG_ER_diArg_1 | 295 | 297 | PF00400 | 0.291 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1I4C8 | Leptomonas seymouri | 78% | 97% | 
| A0A0S4IKH3 | Bodo saltans | 59% | 99% | 
| A0A0S4JA19 | Bodo saltans | 38% | 100% | 
| A0A1X0NRI1 | Trypanosomatidae | 55% | 93% | 
| A0A1X0P9A2 | Trypanosomatidae | 27% | 100% | 
| A0A3Q8IE71 | Leishmania donovani | 37% | 100% | 
| A0A3Q8IIZ5 | Leishmania donovani | 24% | 100% | 
| A0A3R7N7B2 | Trypanosoma rangeli | 25% | 100% | 
| A0A3S7X4R5 | Leishmania donovani | 92% | 100% | 
| A0A3S7X4T7 | Leishmania donovani | 89% | 100% | 
| A0A422N418 | Trypanosoma rangeli | 61% | 99% | 
| A0A422NUW6 | Trypanosoma rangeli | 32% | 100% | 
| A1KN36 | Mycobacterium bovis (strain BCG / Pasteur 1173P2) | 27% | 100% | 
| A4HH09 | Leishmania braziliensis | 36% | 100% | 
| A4HHN0 | Leishmania braziliensis | 25% | 100% | 
| A4HJK3 | Leishmania braziliensis | 75% | 100% | 
| A4HJK8 | Leishmania braziliensis | 82% | 100% | 
| A4HJL5 | Leishmania braziliensis | 76% | 100% | 
| A4I438 | Leishmania infantum | 36% | 100% | 
| A4I4U5 | Leishmania infantum | 24% | 100% | 
| A4I708 | Leishmania infantum | 92% | 100% | 
| A4I738 | Leishmania infantum | 84% | 98% | 
| A5U753 | Mycobacterium tuberculosis (strain ATCC 25177 / H37Ra) | 27% | 100% | 
| C9ZKS4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 100% | 
| C9ZLJ2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 23% | 100% | 
| C9ZME0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 73% | 
| C9ZWP5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 96% | 
| E9ADK3 | Leishmania major | 34% | 100% | 
| E9AE93 | Leishmania major | 25% | 100% | 
| E9ALJ3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% | 
| E9AM78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% | 
| E9B233 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% | 
| O07137 | Mycobacterium leprae (strain TN) | 26% | 100% | 
| O35459 | Mus musculus | 22% | 100% | 
| P14604 | Rattus norvegicus | 24% | 100% | 
| P23965 | Rattus norvegicus | 40% | 100% | 
| P30084 | Homo sapiens | 24% | 100% | 
| P42125 | Mus musculus | 40% | 100% | 
| P42126 | Homo sapiens | 37% | 100% | 
| P52046 | Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) | 22% | 100% | 
| P64017 | Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) | 23% | 100% | 
| P76082 | Escherichia coli (strain K12) | 25% | 100% | 
| P94549 | Bacillus subtilis (strain 168) | 27% | 100% | 
| P9WNN2 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 27% | 100% | 
| P9WNN3 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 27% | 100% | 
| P9WNN8 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 23% | 100% | 
| P9WNN9 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 23% | 100% | 
| Q0AVM1 | Syntrophomonas wolfei subsp. wolfei (strain DSM 2245B / Goettingen) | 25% | 100% | 
| Q13011 | Homo sapiens | 24% | 100% | 
| Q1ZXF1 | Dictyostelium discoideum | 28% | 100% | 
| Q4Q628 | Leishmania major | 82% | 100% | 
| Q4Q636 | Leishmania major | 92% | 100% | 
| Q52995 | Rhizobium meliloti (strain 1021) | 22% | 100% | 
| Q58DM8 | Bos taurus | 25% | 100% | 
| Q5R646 | Pongo abelii | 24% | 100% | 
| Q5RFG0 | Pongo abelii | 24% | 100% | 
| Q62651 | Rattus norvegicus | 22% | 100% | 
| Q7TXE1 | Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) | 27% | 100% | 
| Q8BH95 | Mus musculus | 25% | 100% | 
| V5B2L9 | Trypanosoma cruzi | 61% | 88% | 
| V5BK92 | Trypanosoma cruzi | 31% | 100% | 
| V5DTT7 | Trypanosoma cruzi | 25% | 100% |